Title: Preclinical Evaluation System for Bispecific Antibodies Across Therapeutic Frontiers
Webinar Description:
Bispecific antibodies (bsAbs) have emerged as a powerful therapeutic approach in oncology, autoimmune diseases, and beyond, targeting two distinct antigens or signaling pathways simultaneously. This dual-targeting strategy enhances treatment specificity and efficacy while helping to overcome resistance. As more bsAb candidates advance into clinical trials, robust preclinical evaluation is crucial for their successful translation.
In this webinar, we will explore the expanding role of bsAbs in tackling complex diseases, with a focus on oncology and autoimmune disorders. We’ll also introduce Biocytogen’s cutting-edge in vivo animal models and discuss how these advanced tools support bsAb development, address key challenges, and offer future perspectives.
Join us to gain insights into the evolving bsAb landscape and the innovative tools that accelerate their path to clinical success.
Speaker: Dr. Qiurong Wang
